These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20021342)

  • 1. Estrogens as potential therapeutic agents in multiple sclerosis.
    Niino M; Hirotani M; Fukazawa T; Kikuchi S; Sasaki H
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):87-94. PubMed ID: 20021342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
    Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).
    Gold SM; Sasidhar MV; Morales LB; Du S; Sicotte NL; Tiwari-Woodruff SK; Voskuhl RR
    Lab Invest; 2009 Oct; 89(10):1076-83. PubMed ID: 19668239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-dose estrogen ameliorates experimental autoimmune encephalomyelitis in ovariectomized mice.
    Haghmorad D; Salehipour Z; Nosratabadi R; Rastin M; Kokhaei P; Mahmoudi MB; Amini AA; Mahmoudi M
    J Immunotoxicol; 2016 Nov; 13(6):885-896. PubMed ID: 27602995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous estrogens, through estrogen receptor α, constrain autoimmune inflammation in female mice by limiting CD4+ T-cell homing into the CNS.
    Lélu K; Delpy L; Robert V; Foulon E; Laffont S; Pelletier L; Engelhardt B; Guéry JC
    Eur J Immunol; 2010 Dec; 40(12):3489-98. PubMed ID: 21108469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice.
    Tiwari-Woodruff S; Voskuhl RR
    J Neurol Sci; 2009 Nov; 286(1-2):81-5. PubMed ID: 19442988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis.
    MacKenzie-Graham AJ; Rinek GA; Avedisian A; Morales LB; Umeda E; Boulat B; Jacobs RE; Toga AW; Voskuhl RR
    J Neurosci Res; 2012 Jul; 90(7):1310-23. PubMed ID: 22411609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
    Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
    Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
    Haghmorad D; Amini AA; Mahmoudi MB; Rastin M; Hosseini M; Mahmoudi M
    J Neuroimmunol; 2014 Dec; 277(1-2):85-95. PubMed ID: 25457839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis.
    Lélu K; Laffont S; Delpy L; Paulet PE; Périnat T; Tschanz SA; Pelletier L; Engelhardt B; Guéry JC
    J Immunol; 2011 Sep; 187(5):2386-93. PubMed ID: 21810607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-mediated protection of experimental autoimmune encephalomyelitis: Lessons from the dissection of estrogen receptor-signaling in vivo.
    Laffont S; Garnier L; Lélu K; Guéry JC
    Biomed J; 2015; 38(3):194-205. PubMed ID: 26068028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
    Moliné-Velázquez V; Ortega MC; Vila del Sol V; Melero-Jerez C; de Castro F; Clemente D
    Neurobiol Dis; 2014 Jul; 67():149-64. PubMed ID: 24709559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis.
    Kim S; Liva SM; Dalal MA; Verity MA; Voskuhl RR
    Neurology; 1999 Apr; 52(6):1230-8. PubMed ID: 10214749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease.
    Liu HB; Loo KK; Palaszynski K; Ashouri J; Lubahn DB; Voskuhl RR
    J Immunol; 2003 Dec; 171(12):6936-40. PubMed ID: 14662901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.
    Furlan R; Martino G; Galbiati F; Poliani PL; Smiroldo S; Bergami A; Desina G; Comi G; Flavell R; Su MS; Adorini L
    J Immunol; 1999 Sep; 163(5):2403-9. PubMed ID: 10452974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
    Hahn JN; Kaushik DK; Mishra MK; Wang J; Silva C; Yong VW
    J Immunol; 2016 Nov; 197(10):3850-3860. PubMed ID: 27733550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
    Soldan SS; Alvarez Retuerto AI; Sicotte NL; Voskuhl RR
    J Immunol; 2003 Dec; 171(11):6267-74. PubMed ID: 14634144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.